Quarterly report · Q3

Period2023-03-01 → 2023-11-30
Filed2024-01-12
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 36
MetricValuePeriodScopeSource row
Revenue¥75.9bn2023-03-01 → 2023-11-30Cons.Net sales
Revenue¥99.5bn2022-03-01 → 2023-02-28Cons.Net sales (5-year summary)
Revenue¥73.8bn2022-03-01 → 2022-11-30Cons.Net sales
Operating income¥441m2023-03-01 → 2023-11-30Cons.Operating income
Operating income¥655m2022-03-01 → 2022-11-30Cons.Operating income
Ordinary income¥484m2023-03-01 → 2023-11-30Cons.Ordinary income
Ordinary income¥928m2022-03-01 → 2023-02-28Cons.Ordinary income loss (5-year summary)
Ordinary income¥725m2022-03-01 → 2022-11-30Cons.Ordinary income
Profit before tax¥490m2023-03-01 → 2023-11-30Cons.Income before income taxes
Profit before tax¥628m2022-03-01 → 2022-11-30Cons.Income before income taxes
Net income (owners)¥926m2023-03-01 → 2023-11-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥205m2022-03-01 → 2023-02-28Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥382m2022-03-01 → 2022-11-30Cons.Profit loss attributable to owners of parent
Net income¥926m2023-03-01 → 2023-11-30Cons.Profit loss
Net income¥382m2022-03-01 → 2022-11-30Cons.Profit loss
Total assets¥59.1bnat 2023-11-30Cons.Assets
Total assets¥54.3bnat 2023-02-28Cons.Assets
Total assets¥53.7bnat 2022-11-30Cons.Total assets (5-year summary)
Total liabilities¥29.8bnat 2023-11-30Cons.Liabilities
Total liabilities¥25.6bnat 2023-02-28Cons.Liabilities
Net assets / equity¥29.3bnat 2023-11-30Cons.Net assets
Net assets / equity¥28.6bnat 2023-02-28Cons.Net assets
Net assets / equity¥29.0bnat 2022-11-30Cons.Net assets (5-year summary)
Cash and deposits¥5.4bnat 2023-11-30Cons.Cash and deposits
Cash and deposits¥5.4bnat 2023-02-28Cons.Cash and deposits
EPS (basic)¥85.982023-03-01 → 2023-11-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-9.132023-09-01 → 2023-11-30dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥18.92022-03-01 → 2023-02-28Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥35.052022-03-01 → 2022-11-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-4.722022-09-01 → 2022-11-30dCons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥85.932023-03-01 → 2023-11-30Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥18.882022-03-01 → 2023-02-28Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥35.032022-03-01 → 2022-11-30Cons.Diluted earnings per share (5-year summary)
Equity ratio49.5%at 2023-11-30Cons.Equity to asset ratio (5-year summary)
Equity ratio52.8%at 2023-02-28Cons.Equity to asset ratio (5-year summary)
Equity ratio54.0%at 2022-11-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 46
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2023-03-01 → 2023-11-30¥3.2bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2023-03-01 → 2023-11-30¥7m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2023-03-01 → 2023-11-30¥3.2bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2023-03-01 → 2023-11-30−¥36m
Reconciling Itemsreconcilingrevenue2023-03-01 → 2023-11-30−¥3.7bn
Reconciling Itemsreconcilingrevenue intersegment2023-03-01 → 2023-11-30−¥3.7bn
Reconciling Itemsreconcilingsegment profit2023-03-01 → 2023-11-30¥7m
jpcrp040300-q3r_E03228-000Drugstore Businessreportable segmentrevenue2023-03-01 → 2023-11-30¥9.7bn
jpcrp040300-q3r_E03228-000Drugstore Businessreportable segmentrevenue external2023-03-01 → 2023-11-30¥9.7bn
jpcrp040300-q3r_E03228-000Drugstore Businessreportable segmentrevenue intersegment2023-03-01 → 2023-11-30¥0
jpcrp040300-q3r_E03228-000Drugstore Businessreportable segmentsegment profit2023-03-01 → 2023-11-30¥50m
jpcrp040300-q3r_E03228-000Supermarket Businessreportable segmentrevenue2023-03-01 → 2023-11-30¥66.6bn
jpcrp040300-q3r_E03228-000Supermarket Businessreportable segmentrevenue external2023-03-01 → 2023-11-30¥66.2bn
jpcrp040300-q3r_E03228-000Supermarket Businessreportable segmentrevenue intersegment2023-03-01 → 2023-11-30¥446m
jpcrp040300-q3r_E03228-000Supermarket Businessreportable segmentsegment profit2023-03-01 → 2023-11-30¥419m
—segment totalrevenue2023-03-01 → 2023-11-30¥76.4bn
—segment totalrevenue external2023-03-01 → 2023-11-30¥75.9bn
—segment totalrevenue intersegment2023-03-01 → 2023-11-30¥446m
—segment totalsegment profit2023-03-01 → 2023-11-30¥470m
Total Of Reportable Segments And Otherssegment totalrevenue2023-03-01 → 2023-11-30¥79.6bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-03-01 → 2023-11-30¥75.9bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2023-03-01 → 2023-11-30¥3.7bn
Total Of Reportable Segments And Otherssegment totalsegment profit2023-03-01 → 2023-11-30¥434m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2022-03-01 → 2022-11-30¥3.1bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2022-03-01 → 2022-11-30¥5m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2022-03-01 → 2022-11-30¥3.1bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2022-03-01 → 2022-11-30¥62m
Reconciling Itemsreconcilingrevenue2022-03-01 → 2022-11-30−¥3.5bn
Reconciling Itemsreconcilingrevenue intersegment2022-03-01 → 2022-11-30−¥3.5bn
Reconciling Itemsreconcilingsegment profit2022-03-01 → 2022-11-30¥5m
jpcrp040300-q3r_E03228-000Drugstore Businessreportable segmentrevenue2022-03-01 → 2022-11-30¥9.7bn
jpcrp040300-q3r_E03228-000Drugstore Businessreportable segmentrevenue external2022-03-01 → 2022-11-30¥9.7bn
jpcrp040300-q3r_E03228-000Drugstore Businessreportable segmentrevenue intersegment2022-03-01 → 2022-11-30¥0
jpcrp040300-q3r_E03228-000Drugstore Businessreportable segmentsegment profit2022-03-01 → 2022-11-30¥92m
jpcrp040300-q3r_E03228-000Supermarket Businessreportable segmentrevenue2022-03-01 → 2022-11-30¥64.6bn
jpcrp040300-q3r_E03228-000Supermarket Businessreportable segmentrevenue external2022-03-01 → 2022-11-30¥64.1bn
jpcrp040300-q3r_E03228-000Supermarket Businessreportable segmentrevenue intersegment2022-03-01 → 2022-11-30¥448m
jpcrp040300-q3r_E03228-000Supermarket Businessreportable segmentsegment profit2022-03-01 → 2022-11-30¥494m
—segment totalrevenue2022-03-01 → 2022-11-30¥74.3bn
—segment totalrevenue external2022-03-01 → 2022-11-30¥73.8bn
—segment totalrevenue intersegment2022-03-01 → 2022-11-30¥448m
—segment totalsegment profit2022-03-01 → 2022-11-30¥586m
Total Of Reportable Segments And Otherssegment totalrevenue2022-03-01 → 2022-11-30¥77.4bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-03-01 → 2022-11-30¥73.8bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-03-01 → 2022-11-30¥3.5bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-03-01 → 2022-11-30¥649m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 361
ItemContextValueUnit
Description of fact that quarterly statement of cash flows has not been prepared (text)CurrentYTDDurationText · Plus
Notes regarding dividend (text)Prior1YTDDurationText · Plus
Notes regarding dividend (text)CurrentYTDDurationText · Plus
Notes segment information etc quarterly consolidated financial statements (text)CurrentYTDDurationText · Plus
Footnotes regarding segment information table (text)Prior1YTDDurationText · Plus
Footnotes regarding segment information table (text)CurrentYTDDurationText · Plus
Notes revenue recognition quarterly consolidated financial statements (text)CurrentYTDDurationText · Plus
Notes per share information quarterly consolidated financial statements (text)CurrentYTDDurationText · Plus
Notes significant events after reporting period quarterly consolidated financial statements (text)CurrentYTDDurationText · Plus
Other information consolidated financial statements etc (text)CurrentYTDDurationText · Plus
Information about company which provides guarantee to reporting company (text)FilingDateInstantText · Plus

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2023-02-28pass rounding
balance sheet identityconsolidated 2023-11-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-02-28pass
statement vs summary · net assetsconsolidated 2023-11-30pass
statement vs summary · net income attributable to parentconsolidated 2022-03-01/2022-11-30pass
statement vs summary · net income attributable to parentconsolidated 2023-03-01/2023-11-30pass
statement vs summary · revenueconsolidated 2022-03-01/2022-11-30pass
statement vs summary · revenueconsolidated 2023-03-01/2023-11-30pass
statement vs summary · total assetsconsolidated 2023-02-28pass
statement vs summary · total assetsconsolidated 2023-11-30pass